Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.
Read More…
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Phone866-648-2767
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$204.27 million
Profitability
Miscellaneous
Employees952
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions
What is Tabula Rasa HealthCare's stock symbol?
Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."
How were Tabula Rasa HealthCare's earnings last quarter?
Tabula Rasa HealthCare Inc (NASDAQ:TRHC) posted its earnings results on Thursday, August, 8th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.06 by $0.29. The firm had revenue of $76.26 million for the quarter, compared to analysts' expectations of $70.40 million. Tabula Rasa HealthCare had a positive return on equity of 3.63% and a negative net margin of 7.09%. The business's revenue was up 56.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.20 earnings per share. View Tabula Rasa HealthCare's Earnings History.
When is Tabula Rasa HealthCare's next earnings date?
What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?
Tabula Rasa HealthCare updated its third quarter 2019 earnings guidance on Thursday, August, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $74-77 million, compared to the consensus revenue estimate of $75.82 million.
What price target have analysts set for TRHC?
8 equities research analysts have issued 12 month price objectives for Tabula Rasa HealthCare's shares. Their forecasts range from $58.00 to $99.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $79.04 in the next year. This suggests a possible upside of 51.1% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.
What is the consensus analysts' recommendation for Tabula Rasa HealthCare?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating, 6 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.
Has Tabula Rasa HealthCare been receiving favorable news coverage?
Headlines about TRHC stock have been trending positive this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Tabula Rasa HealthCare earned a news sentiment score of 2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Tabula Rasa HealthCare.
Who are some of Tabula Rasa HealthCare's key competitors?
Some companies that are related to Tabula Rasa HealthCare include Ritchie Bros. Auctioneers (RBA), TriNet Group (TNET), Healthequity (HQY), Envestnet (ENV), WNS (WNS), HMS (HMSY), Sothebys (BID), Farfetch (FTCH), EVO Payments (EVOP), ExlService (EXLS), Wageworks (WAGE), Cardtronics (CATM), Viad (VVI), CBIZ (CBZ) and GreenSky (GSKY).
What other stocks do shareholders of Tabula Rasa HealthCare own?
Who are Tabula Rasa HealthCare's key executives?
Tabula Rasa HealthCare's management team includes the folowing people:
- Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
- Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
- Mr. Brian W. Adams, CFO & Sec. (Age 37)
- Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
- Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)
When did Tabula Rasa HealthCare IPO?
(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.
Who are Tabula Rasa HealthCare's major shareholders?
Tabula Rasa HealthCare's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Peregrine Capital Management LLC (1.38%), Artemis Investment Management LLP (1.00%), State of Alaska Department of Revenue (0.07%) and HMS Capital Management LLC (0.02%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.
Which major investors are selling Tabula Rasa HealthCare stock?
TRHC stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare.
Which major investors are buying Tabula Rasa HealthCare stock?
TRHC stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Artemis Investment Management LLP and HMS Capital Management LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.
How do I buy shares of Tabula Rasa HealthCare?
Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Tabula Rasa HealthCare's stock price today?
One share of TRHC stock can currently be purchased for approximately $52.30.
How big of a company is Tabula Rasa HealthCare?
Tabula Rasa HealthCare has a market capitalization of $1.16 billion and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Tabula Rasa HealthCare employs 952 workers across the globe.View Additional Information About Tabula Rasa HealthCare.
What is Tabula Rasa HealthCare's official website?
How can I contact Tabula Rasa HealthCare?
Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]
MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
